Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …

Recently, RAD51C mutations were identified in families with breast and ovarian cancer 1 .
This observation prompted us to investigate the role of RAD51D in cancer susceptibility. We …

Background Cancer diagnostics and surgery have been disrupted by the response of health
care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of …

In 2010, Meindl and colleagues proposed that germline RAD51C mutations confer high risk
for breast and ovarian cancer, comparable to BRCA1 and BRCA2 mutations1, 2. However, …

Improved sequencing technologies offer unprecedented opportunities for investigating the
role of rare genetic variation in common disease. However, there are considerable …

Mosaic loss of chromosome Y (LOY) in circulating white blood cells is the most common form
of clonal mosaicism 1 , 2 , 3 , 4 – 5 , yet our knowledge of the causes and consequences of …

In-depth molecular investigation of familial leukemia has been limited by the rarity of
recognized cases. This study examines the genetic events initiating leukemia and details the …

To explore the genetic architecture of human overgrowth syndromes and human growth
control, we performed experimental and bioinformatic analyses of 710 individuals with …

The biological processes controlling human growth are diverse, complex and poorly
understood. Genetic factors are important and human height has been shown to be a highly …

Background The purpose of this study was to estimate precise age-specific tubo-ovarian
carcinoma (TOC) and breast cancer (BC) risks for carriers of pathogenic variants in RAD51C …